GeneDx Holdings Corp. Stock Issued
GeneDx Holdings Corp. (WGS) reported Stock Issued of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2024-10-29
- GeneDx Holdings Corp. stock issued for the quarter ending 2024-09-30 was $0.00.
- GeneDx Holdings Corp. stock issued for the quarter ending 2023-12-31 was -$6.69M.
- GeneDx Holdings Corp. stock issued for the quarter ending 2023-09-30 was $0.00.
- GeneDx Holdings Corp. stock issued for the quarter ending 2022-12-31 was $0.00.
- GeneDx Holdings Corp. stock issued for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- GeneDx Holdings Corp. stock issued for fiscal 2022 was $172.00M.
- GeneDx Holdings Corp. stock issued for fiscal 2021 was $0.00.
- GeneDx Holdings Corp. stock issued for fiscal 2020 was $0.00.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 9 month | Stock Issued 9 month as first filed | Stock Issued 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-07-30 | ||||
| 2023-12-31 | -$6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$6.69M derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-K · filed 2024-02-23 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $6.69M 10-Q · filed 2024-10-29 | $0.00 10-Q · filed 2023-11-03 | ||
| 2023-06-30 | $6.69M 10-Q · filed 2024-07-30 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $172.00M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $172.00M 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | $172.00M 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |